Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study.
作者： E. Esteban , M. Majem , M. Martinez Aguillo , N. Martinez Banaclocha , M. Dómine
DOI: 10.1016/J.CANEP.2015.02.003
关键词: Exon 、 Oncology 、 Carcinoma 、 Adenocarcinoma 、 Medicine 、 Lung cancer 、 Mutation rate 、 Mutation testing 、 Internal medicine 、 Pathology 、 Genetic testing 、 Point mutation
摘要: … activating mutation rate of 9.4% (including 0.8% EGFR resistant) was preliminary reported from a large biomolecular study in 10 000 patients with advanced NSCLC in France [20]. In …
cancerepidemiology.net
elsevier.com
researchgate.net 参考文章(32)
E. Steliarova-Foucher, M. Laversanne, J. Ferlay, D. Forman, S. Antoni, Freddie Ian Bray, C. Gombe Mbalawa, B. Kohler, M. Piñeros, D. H. Brewster, I. Soerjomataram, R. Swaminathan, Cancer Incidence in Five Continents ,(1997)
Gilda da Cunha Santos, Mauro Ajaj Saieg, William Geddie, Natasha Leighl, EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities. Cancer Cytopathology. ,vol. 119, pp. 80- 91 ,(2011) , 10.1002/CNCY.20150
Robert L. Dorit, Osamu Ohara, Charles B-C. Hwang, Jae Bum Kim, Seth Blackshaw, Direct DNA sequencing of PCR products. Current protocols in molecular biology. ,vol. 56, ,(2001) , 10.1002/0471142727.MB1502S56
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
Oscar Arrieta, Andrés Felipe Cardona, Guillermo Federico Bramuglia, Aly Gallo, Alma D Campos-Parra, Silvia Serrano, Marcelo Castro, Alejandro Avilés, Edgar Amorin, Ricardo Kirchuk, Mauricio Cuello, José Borbolla, Omar Riemersma, Henry Becerra, Rafael Rosell, None, Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America Journal of Thoracic Oncology. ,vol. 6, pp. 1955- 1959 ,(2011) , 10.1097/JTO.0B013E31822F655F
S Gahr, R Stoehr, E Geissinger, J H Ficker, W M Brueckl, A Gschwendtner, S Gattenloehner, F S Fuchs, C Schulz, R J Rieker, A Hartmann, P Ruemmele, W Dietmaier, EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice British Journal of Cancer. ,vol. 109, pp. 1821- 1828 ,(2013) , 10.1038/BJC.2013.511
AUDREY VALLEE, CHRISTINE SAGAN, ANNE-GAELLE LE LOUPP, KALYANE BACH, THOMAS DEJOIE, MARC G. DENIS, Detection of EGFR gene mutations in non-small cell lung cancer: Lessons from a single-institution routine analysis of 1,403 tumor samples International Journal of Oncology. ,vol. 43, pp. 1045- 1051 ,(2013) , 10.3892/IJO.2013.2056
Natasha Rekhtman, Suzanne M. Brandt, Carlie S. Sigel, Maria A. Friedlander, Gregory J. Riely, William D. Travis, Maureen F. Zakowski, Andre L. Moreira, Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing Journal of Thoracic Oncology. ,vol. 6, pp. 451- 458 ,(2011) , 10.1097/JTO.0B013E31820517A3
Valerie W. Rusch, Marc Ladanyi, Mark G. Kris, J. Matthew Reinersman, Melissa L. Johnson, Gregory J. Riely, Dhananjay A. Chitale, Anthony D. Nicastri, Gerald A. Soff, Ann G. Schwartz, Camelia S. Sima, Getinet Ayalew, Christopher Lau, Maureen F. Zakowski, Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African Americans Journal of Thoracic Oncology. ,vol. 6, pp. 28- 31 ,(2011) , 10.1097/JTO.0B013E3181FB4FE2
Helena Linardou, Issa J. Dahabreh, Dimitrios Bafaloukos, Paris Kosmidis, Samuel Murray, Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC Nature Reviews Clinical Oncology. ,vol. 6, pp. 352- 366 ,(2009) , 10.1038/NRCLINONC.2009.62